Regulatory framework & MRO authority

DOT vs non-DOT testing programs, agency-specific rules (FMCSA, FAA, FRA, USCG, FTA, PHMSA), MRO qualifications and authority, scope of 49 CFR Part 40.

During a verification interview for a laboratory-confirmed negative drug test, a commercial driver reveals they have recently started taking a potent anti-seizure medication for a newly diagnosed seizure disorder. The MRO determines that the driver is likely medically unqualified under FMCSA regulations and that continued performance of safety-sensitive functions poses a significant safety risk. What is the most appropriate action for the MRO to take regarding this medical information?

A.Maintain the confidentiality of the medical disclosure because the laboratory result is negative.

B.Advise the driver to self-report the condition and only notify the employer if the driver refuses to sign a release of information.

C.Document the medical disqualification and safety concern in the Remarks section of the CCF when reporting the negative result to the employer.

D.Provide a separate written communication to the employer explaining the specific nature of the safety concern and the driver's condition.